查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566958

动物助行器市场：依产品类型、动物类型、最终用户：2024-2033 年全球机会分析与产业预测

Animal Aids Market By Product Type , By Animal Type By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 260 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年动物助行器市值为9亿美元，预计2024年至2033年复合年增长率为5.7%，到2033年达到15亿美元。

动物助行器是为动物福利而设计的工具、设备和服务。它们的范围从义肢和轮椅等医疗辅助器具到训练设备和丰富玩具等行为辅助器具。动物助行器还涵盖兽医服务和治疗，透过确保动物获得护理和支持来促进动物福利。

全球动物助行器市场的成长是由于宠物主人数量的增加、社会意识的增强以及对动物福利的关注而推动的。根据美国商业杂誌《富比士顾问》2024年的统计，美国约有8,690万个家庭拥有宠物。随着宠物拥有量的增加，对动物照护产品和服务的需求预计将同步增加，从而推动动物助行器市场的成长。此外，随着宠物寿命的延长和可支配收入的迅速增加，宠物饲主在宠物的健康和福祉上花费更多，从而推动了医疗辅助器具。此外，穿戴式科技和智慧餵食系统的普及也为市场成长做出了重大贡献。例如，GPS追踪器和健康监测器等设备用于追踪宠物的日常活动。此外，宠物饲主越来越多地转向可透过智慧型手机应用程式控制的自动餵食器和饮水器，以提供便利性并确保宠物即使在外出时也能按时餵食和补水，这就是我正在努力做的事情。然而，与先进的动物助行器和兽医治疗相关的高成本以及缺乏接受过高级动物助行器的使用和处方培训的兽医专业人员严重阻碍了市场的成长。相反，促进动物健康和福利的政府支持政策预计将为预测期内全球市场扩张提供有利机会。例如，世界动物卫生组织（WOAH）旨在透过加强兽医服务能力来改善全世界动物的健康和福祉。此外，远端宠物监控服务的日益普及预计将为未来几年的市场成长开闢新的途径。

全球动物助行器市场按产品类型、动物类型、最终用户和地区细分。依产品类型分为药品、营养食品、诊断产品、手术设备和创伤护理产品。依动物种类分为伴同性动物、家畜动物和野生动物。依最终用户划分，可分为兽医院和诊所、动物收容所和救援中心、农场和牧场以及宠物饲主。从区域来看，分析涵盖北美、欧洲、亚太地区和拉丁美洲/中东/非洲。

主要发现

按产品类型划分，到 2023 年，製药领域将在动物助行器市场中占据最大份额。

从动物类型来看，2023年伴同性动物板块是主要股东。

按最终用户划分，兽医院和诊所将在 2023 年占据市场主导地位。

按地区划分，北美是 2023 年的主要收益贡献国家，预计将在未来几年主导市场。

可以使用此报告进行客製化（需要额外费用和时间表）

  • 根据客户兴趣加入公司简介

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 关键投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章动物助行器市场：依产品类型

  • 市场概况
  • 药品
  • 食品补充品
  • 诊断产品
  • 手术设备
  • 创伤护理产品

第五章动物助行器市场：依动物类型

  • 市场概况
  • 伴同性动物
  • 家畜动物
  • 野生动物

第六章动物助行器市场：依最终用户分类

  • 市场概况
  • 动物医院/诊所
  • 动物收容所及救援中心
  • 农场和牧场
  • 宠物饲主

第七章动物助行器市场：按地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国动物助行器市场
    • 加拿大动物助行器市场
    • 墨西哥动物助行器市场
  • 欧洲
    • 主要市场趋势和机会
    • 法国动物助行器市场
    • 德国动物助行器市场
    • 义大利动物助行器市场
    • 西班牙动物助行器市场
    • 英国动物助行器市场
    • 其他欧洲动物助行器市场
  • 亚太地区
    • 主要市场趋势和机会
    • 中国动物助行器市场
    • 日本动物助行器市场
    • 印度动物助行器市场
    • 韩国动物助行器市场
    • 澳洲动物助行器市场
    • 其他亚太地区动物助行器市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西动物助行器市场
    • 南非动物助行器市场
    • 沙乌地阿拉伯动物助行器市场
    • 其他拉丁美洲/中东/非洲动物助行器市场

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第九章 公司简介

  • Zoetis Inc.
  • Boehringer Ingelheim Animal Health
  • Elanco Animal Health
  • Merck Animal Health
  • Bayer Animal Health
  • CEVA Sante Animale SAS
  • Virbac
  • Vetoquinol
  • Dechra Pharmaceuticals Plc.
  • Phibro Animal Health Corporation.
简介目录
Product Code: A324362

The animal aids market was valued at $0.9 billion in 2023, and is projected to reach $1.5 billion by 2033, growing at a CAGR of 5.7% from 2024 to 2033.

Animal aids are tools, devices, and services designed for the well-being of animals. These can range from medical aids like prosthetics and wheelchairs to behavioral aids such as training tools and enrichment toys. Veterinary services and therapeutic treatments are also covered under animal aids, which ensure that animals receive the care and support, thus promoting animal welfare.

The growth of the global animal aids market is driven by rise in pet ownership and increase in public awareness and concern for the well-being of animals. According to the 2024 statistics determined by Forbes Advisor-a U.S.-based business magazine-approximately 86.9 million homes in the U.S. own a pet. With increasing adoption of pets, the demand for animal care products and services is expected to rise simultaneously, thereby fostering the growth of the animal aids market. Furthermore, increase in lifespan of pets and surge in disposable income encourage pet owners to spend more on their pets' health and well-being, thus boosting the sale of medical and supportive aids. Moreover, increase in penetration of wearable technology and smart feeding systems notably contributes toward the growth of the market. For instance, devices such as GPS trackers and health monitors are being used to track the daily activities for pets. In addition, pet owners are increasingly turning to automated feeders and water dispensers that can be controlled via smartphone apps, providing convenience and ensuring their pets are fed and hydrated on schedule even when they are not home. However, high costs associated with advanced animal aids and veterinary treatments and dearth of veterinary professionals trained in using and prescribing advanced animal aids significantly restrain the growth of the market. On the contrary, supportive government policies promoting animal health and welfare are expected to offer lucrative opportunities for the expansion of the global market during the forecast period. For instance, the World Organisation for Animal Health (WOAH) aims to improve global animal health and welfare by enhancing the capacity of veterinary services. Furthermore, increase in penetration of remote monitoring services for pets is expected to open new avenues for the market growth in the coming years.

The global animal aids market is segmented into product type, animal type, end user, and region. On the basis of product type, the market is divided into medicinal products, nutritional supplements, diagnostic products, surgical equipment, and wound care products. By animal type, it is classified into companion animals, livestock animal, and wildlife animal. Depending on end user, it is categorized into veterinary clinics & hospitals, animal shelters & rescue centers, farms & ranches, and pet owners. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By product type, the medicinal product segment accounted for the largest share in 2023 in the animal aids market.

Depending on animal type, the companion animal segment was the major shareholder in 2023.

On the basis of end user, the veterinary clinics & hospitals segment dominated the market in 2023.

Region wise, North America was the key revenue contributor in 2023, and is expected to dominate the market in the coming years.

Competition Analysis

Competitive analysis and profiles of the major players in the global animal aids market include Zoetis Inc., Boehringer Ingelheim Animal Health, Elanco Animal Health, Merck Animal Health, Bayer Animal Health, CEVA Sante Animale S.A.S., Virbac, Vetoquinol, Dechra Pharmaceuticals Plc., and Phibro Animal Health Corporation. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest

Key Market Segments

By Product Type

  • Medicinal Products
  • Nutritional Supplements
  • Diagnostic Products
  • Surgical Equipment
  • Wound Care Products

By Animal Type

  • Companion Animals
  • Livestock Animal
  • Wildlife Animal.

By End User

  • Veterinary Clinics and Hospitals
  • Animal Shelters and Rescue Center
  • Farms and Ranches
  • Pet Owners

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Zoetis Inc.
    • Boehringer Ingelheim Animal Health
    • Elanco Animal Health
    • Merck Animal Health
    • Bayer Animal Health
    • CEVA Sante Animale S.A.S.
    • Virbac
    • Vetoquinol
    • Dechra Pharmaceuticals plc.
    • Phibro Animal Health Corporation.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: ANIMAL AIDS MARKET, BY PRODUCT TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product Type
  • 4.2. Medicinal Products
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Nutritional Supplements
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Diagnostic Products
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Surgical Equipment
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country
  • 4.6. Wound Care Products
    • 4.6.1. Key Market Trends, Growth Factors and Opportunities
    • 4.6.2. Market Size and Forecast, By Region
    • 4.6.3. Market Share Analysis, By Country

CHAPTER 5: ANIMAL AIDS MARKET, BY ANIMAL TYPE

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Animal Type
  • 5.2. Companion Animals
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Livestock Animal
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Wildlife Animal.
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: ANIMAL AIDS MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Veterinary Clinics And Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Animal Shelters And Rescue Center
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Farms And Ranches
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country
  • 6.5. Pet Owners
    • 6.5.1. Key Market Trends, Growth Factors and Opportunities
    • 6.5.2. Market Size and Forecast, By Region
    • 6.5.3. Market Share Analysis, By Country

CHAPTER 7: ANIMAL AIDS MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Product Type
    • 7.2.3. Market Size and Forecast, By Animal Type
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Animal Aids Market
      • 7.2.6.1. Market Size and Forecast, By Product Type
      • 7.2.6.2. Market Size and Forecast, By Animal Type
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Animal Aids Market
      • 7.2.7.1. Market Size and Forecast, By Product Type
      • 7.2.7.2. Market Size and Forecast, By Animal Type
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Animal Aids Market
      • 7.2.8.1. Market Size and Forecast, By Product Type
      • 7.2.8.2. Market Size and Forecast, By Animal Type
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Product Type
    • 7.3.3. Market Size and Forecast, By Animal Type
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Animal Aids Market
      • 7.3.6.1. Market Size and Forecast, By Product Type
      • 7.3.6.2. Market Size and Forecast, By Animal Type
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Animal Aids Market
      • 7.3.7.1. Market Size and Forecast, By Product Type
      • 7.3.7.2. Market Size and Forecast, By Animal Type
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Animal Aids Market
      • 7.3.8.1. Market Size and Forecast, By Product Type
      • 7.3.8.2. Market Size and Forecast, By Animal Type
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Animal Aids Market
      • 7.3.9.1. Market Size and Forecast, By Product Type
      • 7.3.9.2. Market Size and Forecast, By Animal Type
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Animal Aids Market
      • 7.3.10.1. Market Size and Forecast, By Product Type
      • 7.3.10.2. Market Size and Forecast, By Animal Type
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Animal Aids Market
      • 7.3.11.1. Market Size and Forecast, By Product Type
      • 7.3.11.2. Market Size and Forecast, By Animal Type
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Product Type
    • 7.4.3. Market Size and Forecast, By Animal Type
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Animal Aids Market
      • 7.4.6.1. Market Size and Forecast, By Product Type
      • 7.4.6.2. Market Size and Forecast, By Animal Type
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Animal Aids Market
      • 7.4.7.1. Market Size and Forecast, By Product Type
      • 7.4.7.2. Market Size and Forecast, By Animal Type
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Animal Aids Market
      • 7.4.8.1. Market Size and Forecast, By Product Type
      • 7.4.8.2. Market Size and Forecast, By Animal Type
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Animal Aids Market
      • 7.4.9.1. Market Size and Forecast, By Product Type
      • 7.4.9.2. Market Size and Forecast, By Animal Type
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Animal Aids Market
      • 7.4.10.1. Market Size and Forecast, By Product Type
      • 7.4.10.2. Market Size and Forecast, By Animal Type
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Animal Aids Market
      • 7.4.11.1. Market Size and Forecast, By Product Type
      • 7.4.11.2. Market Size and Forecast, By Animal Type
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Product Type
    • 7.5.3. Market Size and Forecast, By Animal Type
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Animal Aids Market
      • 7.5.6.1. Market Size and Forecast, By Product Type
      • 7.5.6.2. Market Size and Forecast, By Animal Type
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Animal Aids Market
      • 7.5.7.1. Market Size and Forecast, By Product Type
      • 7.5.7.2. Market Size and Forecast, By Animal Type
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Animal Aids Market
      • 7.5.8.1. Market Size and Forecast, By Product Type
      • 7.5.8.2. Market Size and Forecast, By Animal Type
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Animal Aids Market
      • 7.5.9.1. Market Size and Forecast, By Product Type
      • 7.5.9.2. Market Size and Forecast, By Animal Type
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Zoetis Inc.
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Boehringer Ingelheim Animal Health
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Elanco Animal Health
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Merck Animal Health
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Bayer Animal Health
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. CEVA Sante Animale S.A.S.
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Virbac
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Vetoquinol
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Dechra Pharmaceuticals Plc.
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Phibro Animal Health Corporation.
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments